DK159163C - Fremgangsmaade til fremstilling af et tarm-glucagon-antistof - Google Patents

Fremgangsmaade til fremstilling af et tarm-glucagon-antistof

Info

Publication number
DK159163C
DK159163C DK222081A DK222081A DK159163C DK 159163 C DK159163 C DK 159163C DK 222081 A DK222081 A DK 222081A DK 222081 A DK222081 A DK 222081A DK 159163 C DK159163 C DK 159163C
Authority
DK
Denmark
Prior art keywords
procedure
manufacturing
gas
glucagon antibody
glucagon
Prior art date
Application number
DK222081A
Other languages
Danish (da)
English (en)
Other versions
DK159163B (da
DK222081A (da
Inventor
Noboru Yanaihara
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of DK222081A publication Critical patent/DK222081A/da
Publication of DK159163B publication Critical patent/DK159163B/da
Application granted granted Critical
Publication of DK159163C publication Critical patent/DK159163C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/822—Identified hapten
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK222081A 1980-05-21 1981-05-20 Fremgangsmaade til fremstilling af et tarm-glucagon-antistof DK159163C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6804080 1980-05-21
JP6804080A JPS56163456A (en) 1980-05-21 1980-05-21 Preparation of antigen

Publications (3)

Publication Number Publication Date
DK222081A DK222081A (da) 1981-11-22
DK159163B DK159163B (da) 1990-09-10
DK159163C true DK159163C (da) 1991-02-11

Family

ID=13362282

Family Applications (1)

Application Number Title Priority Date Filing Date
DK222081A DK159163C (da) 1980-05-21 1981-05-20 Fremgangsmaade til fremstilling af et tarm-glucagon-antistof

Country Status (8)

Country Link
US (1) US4407965A (fr)
JP (1) JPS56163456A (fr)
BE (1) BE888906A (fr)
DE (1) DE3120312C2 (fr)
DK (1) DK159163C (fr)
FR (1) FR2482861A1 (fr)
GB (1) GB2079289B (fr)
SE (1) SE454301B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4572800A (en) * 1982-09-30 1986-02-25 Otsuka Pharmaceutical Co., Ltd. Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies
CA1256795A (fr) * 1983-12-28 1989-07-04 Dennis A. Carson Anticorps anti-idiotype induits par des polypeptides de synthese
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
US4654419A (en) * 1984-08-08 1987-03-31 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen
US5116725A (en) * 1984-08-08 1992-05-26 Scripps Clinic And Research Foundation Assay for Epstein-Barr virus infection with solid phase bound synthetic polypeptides
EP0196319B1 (fr) * 1984-09-19 1992-01-02 The Regents Of The University Of California Polypeptides retroviraux associes a la transformation de cellules humaines
US4732863A (en) * 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
JPH0792458B2 (ja) * 1986-03-14 1995-10-09 郁男 山科 糖鎖特異抗体アツセイプレ−ト及びその製造方法
US5202270A (en) * 1986-05-15 1993-04-13 Abbott Laboratories Cocaine and cocaine metabolites assay tracers, immunogens and antibodies
US6958148B1 (en) 1998-01-20 2005-10-25 Pericor Science, Inc. Linkage of agents to body tissue using microparticles and transglutaminase
US6919076B1 (en) 1998-01-20 2005-07-19 Pericor Science, Inc. Conjugates of agents and transglutaminase substrate linking molecules
CA2960763A1 (fr) 2014-09-16 2016-03-24 Regeneron Pharmaceuticals, Inc. Anticorps anti-glucagon et leurs utilisations
EP3506940A1 (fr) 2016-08-30 2019-07-10 Regeneron Pharmaceuticals, Inc. Procédés de traitement de la résistance à l'insuline grave par interférence avec la signalisation du récepteur du glucagon
WO2018075792A1 (fr) 2016-10-20 2018-04-26 Regeneron Pharmaceuticals, Inc. Méthodes d'abaissement de niveaux de glycémie
CA3071387A1 (fr) 2017-08-22 2019-02-28 Regeneron Pharmaceuticals, Inc. Methodes de traitement des troubles lies au cycle de l'uree par interference avec la signalisation du recepteur du glucagon

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5836308B2 (ja) * 1977-02-10 1983-08-08 大塚製薬株式会社 抗体の製造方法
US4206199A (en) * 1977-07-22 1980-06-03 Takeda Chemical Industries, Ltd. Novel glucagon fragment and its derivatives

Also Published As

Publication number Publication date
FR2482861B1 (fr) 1983-09-09
DK159163B (da) 1990-09-10
SE454301B (sv) 1988-04-18
BE888906A (fr) 1981-11-23
JPS56163456A (en) 1981-12-16
DK222081A (da) 1981-11-22
US4407965A (en) 1983-10-04
JPS6223822B2 (fr) 1987-05-25
SE8103198L (sv) 1981-11-22
GB2079289B (en) 1983-10-26
FR2482861A1 (fr) 1981-11-27
DE3120312C2 (de) 1985-08-29
DE3120312A1 (de) 1982-03-04
GB2079289A (en) 1982-01-20

Similar Documents

Publication Publication Date Title
DK362781A (da) Fremgangsmaade til fremstilling af en kapsel
DK154333C (da) Fremgangsmaade til fremstilling af et formstofnet
DK329079A (da) Fremgangsmaade til fremstilling af et bygningselement
DK156624C (da) Fremgangsmaade til fremstilling af en gel med gastransporterende egenskaber
DK153796C (da) Fremgangsmaade til fremstilling af et polyurethanskum.
DK127780A (da) Fremgangsmaade til fremstilling af mikrokapsler specielt mikrokapsler indeholdende et herbicid
DK157977C (da) Fremgangsmaade til fremstilling af et vaevsklaebestof
DK159163C (da) Fremgangsmaade til fremstilling af et tarm-glucagon-antistof
DK343581A (da) Fremgangsmaade til fremstilling af et triamterenpraeparat
DK157340C (da) Fremgangsmaade til fremstilling af et pancreatisk glucagonspecifikt antistof
DK150914C (da) Byggesaet til opbygning af et gelaender
DK1584D0 (da) Fremgangsmade til fremstilling af et gitterkernesandwichelement
DK140181A (da) Fremgangsmaade til fremstilling af en taendingselektrode
DK528379A (da) Fremgangsmaade til fremstilling af et byggeelement
DK387081A (da) Apparat til frembringelse af en frem-og tilbagegaaende bevaegelse
DK44181A (da) Fremgangsmaade til fremstilling af humant relaxin
NO813270L (no) Fremgangsmaate til fremstilling av et leddet belte
DK404181A (da) Fremgangsmaade til fremstilling af cephalosporiner
DK224681A (da) Fremgangsmaade til fremstilling af diaet-oel
DK87082A (da) Fremgangsmaade til fremstilling af cemnetklinker
DK150336C (da) Fremgangsmaade til fremstilling af en forstaerket ketsjerramme
DK223781A (da) Fremgangsmaade til fremstilling af modificerede chrysotilasbestfibre
DK292681A (da) Fremgangsmaade til fremstilling af et macrolid
DK471181A (da) Fremgangsmaade til fremstilling af et pyrimidinderivat
DK153326C (da) Fremgangsmaade til fremstilling af azoforbindelser

Legal Events

Date Code Title Description
PBP Patent lapsed